Published in AIDS Weekly, October 14th, 2002
Desano Shanghai will be allowed to make a low-cost version of dd1, a widely used drug that slows the effects of AIDS, said Li Jinliang, the company's deputy manager.
Bristol-Myers Squibb holds a patent in China for dd1. A spokesman for the New York-based pharmaceutical company said it only covers the drug in tablet form. He said Desano Shanghai's generic version is exempt because it is a powder.
"They are free to make this,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.